Rapamycin	NN
regulates	VBZ
connective-tissue-growth-factor	NN
expression	NN
of	IN
lung	NN
epithelial	JJ
cells	NNS
via	IN
phosphoinositide-3-kinase	NN
.	.

The	DT
pathogenesis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
remains	VBZ
largely	RB
unknown	JJ
.	.

It	PRP
is	VBZ
believed	VBN
that	IN
IPF	NN
is	VBZ
mainly	RB
driven	VBN
by	IN
activated	VBN
alveolar	JJ
epithelial	JJ
cells	NNS
that	WDT
have	VBP
a	DT
compromised	VBN
migration	NN
capacity	NN
,	,
and	CC
that	IN
also	RB
produce	VBP
substances	NNS
(	(
such	JJ
as	IN
connective-tissue-growth-factor	NN
,	,
CTGF	NN
)	)
that	WDT
contribute	VBP
to	TO
fibroblast	NN
activation	NN
and	CC
matrix	NN
protein	NN
accumulation	NN
.	.

Because	IN
the	DT
mechanisms	NNS
regulating	VBG
these	DT
processes	NNS
are	VBP
unclear	JJ
,	,
the	DT
aim	NN
of	IN
this	DT
study	NN
was	VBD
to	TO
determine	VB
the	DT
role	NN
of	IN
rapamycin	NN
in	IN
regulating	VBG
epithelial	JJ
cell	NN
migration	NN
and	CC
CTGF	NN
expression	NN
.	.

Transformed	VBN
epithelial	JJ
cell	NN
line	NN
A549	NN
and	CC
normal	JJ
human	JJ
pulmonary	JJ
alveolar	JJ
or	CC
bronchial	JJ
epithelial	JJ
cells	NNS
were	VBD
cultured	VBN
in	IN
regular	JJ
medium	NN
or	CC
medium	NN
containing	VBG
rapamycin	NN
.	.

Real	JJ
time	NN
reverse	JJ
transcriptase	NN
polymerase	NN
chain	NN
reaction	NN
was	VBD
employed	VBN
to	TO
determine	VB
CTGF	NN
mRNA	NN
expression	NN
.	.

Western	NN
blotting	NN
and	CC
an	DT
enzyme-linked	JJ
immunosorbent	JJ
assay	NN
were	VBD
used	VBN
for	IN
detecting	VBG
CTGF	NN
protein	NN
.	.

Wound	NN
healing	NN
and	CC
migration	NN
assays	NNS
were	VBD
used	VBN
to	TO
determine	VB
the	DT
cell	NN
migration	NN
potential	NN
.	.

Transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
type	NN
I	CD
receptor	NN
(	(
TbRI	NN
)	)
inhibitor	NN
,	,
SB431542	NN
and	CC
phosphoinositide-3-kinase	NN
(	(
PI3K	NN
)	)
inhibitor	NN
,	,
LY294002	NN
were	VBD
used	VBN
to	TO
determine	VB
rapamycin	NN
's	POS
mechanism	NN
of	IN
action	NN
.	.

It	PRP
was	VBD
found	VBN
that	IN
treatment	NN
of	IN
A549	NN
and	CC
normal	JJ
human	JJ
alveolar	JJ
or	CC
bronchial	JJ
epithelial	JJ
cells	NNS
with	IN
rapamycin	NN
significantly	RB
promoted	VBD
basal	JJ
or	CC
TGF-b1	NN
induced	VBD
CTGF	NN
expression	NN
.	.

LY294002	NN
,	,
not	RB
SB431542	NN
attenuated	VBD
the	DT
promotional	JJ
effect	NN
of	IN
rapamycin	NN
on	IN
CTGF	NN
expression	NN
.	.

Cell	NN
mobility	NN
was	VBD
not	RB
affected	VBN
by	IN
rapamycin	NN
in	IN
wound	NN
healing	NN
and	CC
migration	NN
assays	NNS
.	.

These	DT
data	NNS
suggest	VBP
rapamycin	NN
has	VBZ
a	DT
profibrotic	JJ
effect	NN
in	FW
vitro	FW
and	CC
underscore	VBP
the	DT
potential	NN
of	IN
combined	JJ
therapeutic	JJ
approach	NN
with	IN
PI3K	NN
and	CC
mammalian	JJ
target	NN
of	IN
rapamycin	NN
inhibitors	NNS
for	IN
the	DT
treatment	NN
of	IN
animal	NN
or	CC
human	JJ
lung	NN
fibrosis	NN
.	.

